Speaker Profile
Biography
Dr. Masha Stromme is a scientist, investor and entrepreneur within precision medicine with a focus on genetics and neuroscience. Her current portfolio of companies includes Exact-Tx, a company spun out of GE Healthcare that uses ultrasound technology for targeted drug delivery, Atropos Health, a spin-off of Stanford, focused on making real-world evidence available to clinicians and biopharmas, and ALS-focused GenieUs Genomics and Perron Institute, patient-centric approaches leveraging cutting-edge genomics and gene modulation technologies to advance ALS diagnostics and therapeutics. Mashas early research focused on the molecular mechanisms underlying mitochondrial dysfunction in the developing and the degenerating brain. She transitioned in the late '90s from a scientific career to investment banking, working with Morgan Stanley, Altium Capital and Arctic Securities. In the last 10 years, Masha has leveraged her scientific and investment banking expertise to drive success in early stage investing and building companies based on novel precision health technologies.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Maggie Chapman, Labcorp
- Cross-Application of Oncology Drugs in Rare Diseases
- Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony
Luminary Honoree: David R. Liu, Broad Institute & Crystal Mackal, Stanford University
Pioneer Honoree: Drew Weissman, Penn Medicine
- Keynote: Base Editing, Prime Editing, and Targeted Gene Integration: Precision Therapeutic Genome Editingn
- David R. Liu, Broad Institute
- Breakthroughs in Cancer Immunotherapy: mRNA Vaccines and CAR T-Cell Advances (PANEL)
Chair: Rick Klausner, Altos Labs
- Drew Weissman, Penn Medicine
- Ira Mellman, Formelly with Genentech
- Crystal Mackal, Stanford University - Next-Generation ADCs: Challenges and Innovations in Immunotherapy Combinations (PANEL)
Chair: Sandhya Girish, Gilead
- Bin Liu, UCSF
- Hanspeter Gerber, Sutro Bioscience
- Stephen Eck, MacroGenics - Strategic IP Management in Cell and Gene Therapy: Navigating Legal and Practical Challenges
- Janet Xiao, Morrison & Foerster LLP
- Advances in Allogeneic Cell Therapies: Overcoming Hurdles and Expanding Applications (PANEL)
Chair: Elliot Norry, Adaptimmune
- Larry Lamb, IN8bio
- Indu Ramachandran, Century Therapeutics - Collaborations Advancing Genetics-based Diagnostic Testing for Cell and Gene Therapy
Chair: Maggie Chapman, Labcorp
- Transforming Cancer Treatment: Stem Cell and Gene Therapy Breakthroughs
Chair: Catriona Jamieson, UCSD Health
- Irv Weisman, Stanford
- Bottlenecks in Manufacturing of Cell Therapies
Chair: Fabian Gerlinghaus, Cellares
- Advancements and Future Directions in Therapeutic Ultrasound for Precision Medicine
Chair: Masha Stromme, EXACT Therapeutics
- Bradford Elmer, Sanofi
- John de Groot, UCSF
- Raag Airan, Stanford